{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:01:45Z","timestamp":1696222905860},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/nan.0b013e318288a103","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T09:55:39Z","timestamp":1365069339000},"page":"172-178","source":"Crossref","is-referenced-by-count":1,"title":["Rituximab Faster Infusion for Patients With Non-Hodgkin's Lymphoma in the United States"],"prefix":"10.1097","volume":"36","author":[{"given":"Keith","family":"Dawson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"10","key":"R2-3-20210208","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1182\/blood-2006-11-059469","article-title":"Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting.","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"issue":"5","key":"R3-3-20210208","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12185-010-0583-z","article-title":"A prospective study to evaluate the feasibility and economic benefits of rapid infusion rituximab at an Asian cancer center.","volume":"91","author":"Chiang","year":"2010","journal-title":"Int J Hematol"},{"issue":"2","key":"R4-3-20210208","first-page":"493","article-title":"A nurse can safely deliver rituximab over 90 minutes.","volume":"34","author":"Corey","year":"2007","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"R5-3-20210208","first-page":"1","article-title":"Rapid infusion of rituximab works in community setting.","volume":"5","author":"Coulter","year":"2010","journal-title":"Clin Oncol News"},{"key":"R6-3-20210208","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S1548-5315(11)70426-0","article-title":"Assessment of safety regarding rapid rituximab infusion.","volume":"7","author":"Swan","year":"2010","journal-title":"Community Oncol"},{"issue":"6","key":"R8-3-20210208","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1634\/theoncologist.2008-0012","article-title":"Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.","volume":"13","author":"Chung","year":"2008","journal-title":"Oncologist"},{"issue":"2","key":"R9-3-20210208","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1188\/10.CJON.E10-E21","article-title":"Infusion reactions: diagnosis, assessment, and management.","volume":"14","author":"Vogel","year":"2010","journal-title":"Clin J Oncol Nurs"},{"issue":"3","key":"R11-3-20210208","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1078155208100527","article-title":"Rapid infusion rituximab changing practice for patient care.","volume":"15","author":"Zahrani","year":"2009","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"R12-3-20210208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00520-007-0329-5","article-title":"Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences.","volume":"16","author":"Schwartzberg","year":"2008","journal-title":"Support Care Cancer"},{"issue":"4","key":"R14-3-20210208","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1440-172X.2011.01950.x","article-title":"Safety of rapid rituximab infusion in adult cancer patients: a systematic review.","volume":"17","author":"Lang","year":"2011","journal-title":"Int J Nurs Pract"},{"issue":"2","key":"R15-3-20210208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JOP.200001","article-title":"Review of the safety and feasibility of rapid infusion of rituximab.","volume":"6","author":"Atmar","year":"2010","journal-title":"J Oncol Pract"},{"issue":"2","key":"R21-3-20210208","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/01.NAN.0000313654.57786.bb","article-title":"Infusion reactions triggered by monoclonal antibodies treating solid tumors.","volume":"31","author":"Carney","year":"2008","journal-title":"J Infus Nurs"},{"issue":"3","key":"R22-3-20210208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00129804-200505000-00004","article-title":"Improving patient outcomes in an ambulatory infusion setting: decreasing infusion reactions of patients receiving paclitaxel and carboplatin.","volume":"28","author":"Huddleston","year":"2005","journal-title":"J Infus Nurs"},{"issue":"7","key":"R23-3-20210208","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/annonc\/mdp535","article-title":"Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab.","volume":"21","author":"Foley","year":"2010","journal-title":"Ann Oncol"},{"issue":"6","key":"R24-3-20210208","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1188\/10.CJON.735-741","article-title":"Nursing takes time: workload associated with administering cancer protocols.","volume":"14","author":"de Raad","year":"2010","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"R26-3-20210208","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00520-008-0474-5","article-title":"Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study.","volume":"17","author":"Schwartzberg","year":"2009","journal-title":"Support Care Cancer"},{"issue":"3","key":"R27-3-20210208","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.NAN.0000270674.13439.5b","article-title":"The impact of infusion reactions on oncology patients and clinicians in the inpatient and outpatient practice settings: oncology nurses perspectives.","volume":"30","author":"Colwell","year":"2007","journal-title":"J Infus Nurs"},{"issue":"2","key":"R28-3-20210208","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1188\/10.ONF.E84-E91","article-title":"Oncology nurses perceptions about involving patients in the prevention of chemotherapy administration errors.","volume":"37","author":"Schwappach","year":"2010","journal-title":"Oncol Nurs Forum"},{"issue":"6","key":"R29-3-20210208","doi-asserted-by":"crossref","first-page":"E147","DOI":"10.1188\/04.ONF.E147-E156","article-title":"The Oncology Nursing Society ambulatory office nurse survey.","volume":"31","author":"Ireland","year":"2004","journal-title":"Oncol Nurs Forum"}],"container-title":["Journal of Infusion Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/NAN.0b013e318288a103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:44:09Z","timestamp":1620963849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129804-201305000-00003"}},"subtitle":["Implications for Nursing Practice"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/nan.0b013e318288a103","relation":{},"ISSN":["1533-1458"],"issn-type":[{"value":"1533-1458","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}